Telix Pharmaceuticals

Telix is a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.

Telix’s extensive pipeline for urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning is underpinned by a strong global supply, manufacturing and distribution network.

Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the U.S. Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent and has more than 18 clinical trials underway worldwide.
View More
Top 10 Events
Event Name Amount Members
New York City Run/Walk

$0

1

Reno Run/Walk

$0

1

Charlotte Run/Walk

$0

1

Sacramento Run/Walk

$0

1

Philadelphia Run/Walk

$0

1

Cincinnati Run/Walk

$0

1

Chicago-SEA Blue Run/Walk

$0

1

Top 10 Teams
Top 10 Participants
Participant Name Event Name Amount
Andrea Millers Greensboro Run/Walk

$0

Andrea Millers South Jersey Run/Walk

$0

Andrea Millers North Jersey Run/Walk

$0

Andrea Millers South Florida Run/Walk

$0

Andrea Millers Boston Run/Walk

$0

Andrea Millers Sacramento Run/Walk

$0

Andrea Millers Charlotte Run/Walk

$0

Andrea Millers Austin Run/Walk

$0

Andrea Millers Chicago-SEA Blue Run/Walk

$0

Andrea Millers San Diego Run/Walk

$0